Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved preerythrocytic liver-stage antigen 3

被引:136
作者
Daubersies, P
Thomas, AW
Millet, P
Brahimi, K
Langermans, JAM
Ollomo, B
Ben Mohamed, L
Slierendregt, B
Eling, W
Van Belkum, A
Dubreuil, G
Meis, JFGM
Guérin-Marchand, C
Cayphas, S
Cohen, J
Gras-Masse, H
Druilhe, P
机构
[1] Inst Pasteur, Unite Parasitol Biomed, F-75015 Paris, France
[2] Biomed Primate Res Ctr, Dept Parasitol, NL-2280 GH Rijswijk, Netherlands
[3] Ctr Int Rech Med Franceville, Franceville, Gabon
[4] Univ Nijmegen, Dept Med Microbiol, Nijmegen, Netherlands
[5] Univ Nijmegen, Dept Med Parasitol, Nijmegen, Netherlands
[6] SmithKline Beecham Biol SA, B-1330 Rixensart, Belgium
[7] Inst Pasteur, Lab Chim Biomol, CNRS, URA 1309, F-59019 Lille, France
关键词
D O I
10.1038/81366
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In humans, sterile immunity against malaria can be consistently induced through exposure to the bites of thousands of irradiated infected mosquitoes. The same level of protection has yet to be achieved using subunit vaccines. Recent studies have indicated an essential function for intrahepatic parasites, the stage after the mosquito bite, and thus for antigens expressed during this stage. We report here the identification of liver-stage antigen 3, which is expressed both in the mosquito and liver-stage parasites. This Plasmodium falciparum 200-kilodalton protein is highly conserved, and showed promising antigenic and immunogenic properties. In chimpanzees (Pan troglodytes), the primates most closely related to humans and that share a similar susceptibility to P. falciparum liver-stage infection, immunization with LSA-3 induced protection against successive heterologous challenges with large numbers of P. falciparum sporozoites.
引用
收藏
页码:1258 / 1263
页数:6
相关论文
共 32 条
  • [1] Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3
    Aidoo, M
    Lalvani, A
    Gilbert, SC
    Hu, JT
    Daubersies, P
    Hurt, N
    Whittle, HC
    Druihle, P
    Hill, AVS
    [J]. INFECTION AND IMMUNITY, 2000, 68 (01) : 227 - 232
  • [2] Malaria vaccines
    Anders, RF
    Saul, A
    [J]. PARASITOLOGY TODAY, 2000, 16 (10): : 444 - 447
  • [3] [Anonymous], 1997, NEW ENGL J MED, DOI DOI 10.1056/NEJM199701093360202
  • [4] PLASMODIUM-FALCIPARUM - D260, AN INTRAERYTHROCYTIC PARASITE PROTEIN, IS A MEMBER OF THE GLUTAMIC-ACID DIPEPTIDE-REPEAT FAMILY OF PROTEINS
    BARNES, DA
    WOLLISH, W
    NELSON, RG
    LEECH, JH
    PETERSEN, C
    [J]. EXPERIMENTAL PARASITOLOGY, 1995, 81 (01) : 79 - 89
  • [5] High immunogenicity in chimpanzees of peptides and lipopeptides derived from four new Plasmodium falciparum pre-erythrocytic molecules
    Benmohamed, L
    Thomas, A
    Bossus, M
    Brahimi, K
    Wubben, J
    Gras-Masse, H
    Druilhe, P
    [J]. VACCINE, 2000, 18 (25) : 2843 - 2855
  • [6] Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees
    BenMohamed, L
    GrasMasse, H
    Tartar, A
    Daubersies, P
    Brahimi, K
    Bossus, M
    Thomas, A
    Druilhe, P
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (05) : 1242 - 1253
  • [7] Bottius E, 1996, J IMMUNOL, V156, P2874
  • [8] BOURGAULT I, 1994, J IMMUNOL, V152, P2530
  • [9] SPECIES-SPECIFIC AND STAGE-SPECIFIC ANTIGENS IN EXOERYTHROCYTIC STAGES OF PLASMODIUM-FALCIPARUM
    DRUILHE, P
    PUEBLA, RM
    MILTGEN, F
    PERRIN, L
    GENTILINI, M
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1984, 33 (03) : 336 - 341
  • [10] Druilhe P., 1998, MALARIA PARASITE BIO, P513